This announcement is a separate document:
昂利康：东方证券承销保荐有限公司关于浙江昂利康制药股份有限公司使用2020年非公开发行股票闲置募集资金暂时补充流动资金的核查意见
Zhejiang Anglikang Pharmaceutical: Orient Securities Co., Ltd.'s underwriting and sponsorship opinion for Zhejiang Anglikang Pharmaceutical Co., Ltd.'s use of idle funds from the 2020 non-public offering of stocks to temporarily supplement working capital.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated